Ontology highlight
ABSTRACT: Background
Knowledge, attitudes and substitution laws of biosimilars are not consistent across countries. Biosimilar acceptance among patients and healthcare professionals may be suffering from gaps in knowledge and understanding about biosimilars and their regulatory approval process. Pharmacists' roles and responsibilities changed considerably during the COVID-19 pandemic. Thus, they might have gained new skills and self-confidence in counseling and substitution of biosimilars.Aims
To examine and compare the knowledge, perceptions and information needs of German and Swiss pharmacists regarding original biologicals and biosimilars in 2020 and 2022.Methods
We conducted an online survey among Swiss and German community pharmacies in February 2020 (before) and August
SUBMITTER: Messner K
PROVIDER: S-EPMC10726545 | biostudies-literature | 2023 Dec
REPOSITORIES: biostudies-literature